Summary
Elevance Health, Inc. (then WellPoint, Inc.) filed an 8-K on May 27, 2011, to report significant changes in its executive leadership, specifically within its accounting and finance departments. The most notable event is the appointment of John E. Gallina as the new Chief Accounting Officer (CAO), effective immediately on May 26, 2011. Mr. Gallina's appointment follows the departure of Martin L. Miller from the CAO role, with the company stating Mr. Miller's exit was without cause and unrelated to financial statements or accounting practices. Mr. Gallina, with extensive internal experience at the company since 1994, also assumes the roles of Senior Vice President, Controller, and Chief Risk Officer. Furthermore, the filing announces the upcoming arrival of Jeffrey P. Fusile as Senior Vice President and Chief Financial Officer, Strategic Business Units and Centers of Enterprise Excellence, succeeding George L. Walker who is retiring after a long tenure. Mr. Fusile brings over 20 years of finance and accounting experience, with a significant focus on the healthcare industry, having previously been with PricewaterhouseCoopers, LLP. These leadership changes signal a transition in key financial oversight and strategic financial roles within the company.
Key Highlights
- 1Appointment of John E. Gallina as Chief Accounting Officer (CAO) effective May 26, 2011.
- 2Gallina also appointed Senior Vice President, Controller, and Chief Risk Officer.
- 3Martin L. Miller departed as CAO, with his departure stated to be without cause and unrelated to financial reporting.
- 4Gallina has significant internal experience with the company, holding various finance roles since 1994.
- 5Grant of restricted stock units valued at approximately $150,000 to John E. Gallina upon his appointment.
- 6Jeffrey P. Fusile to join as Senior Vice President and Chief Financial Officer, Strategic Business Units and Centers of Enterprise Excellence.
- 7George L. Walker is retiring after 28 years with the company.